ES2281894T3 - CONDON WITH A COATING AND COMPOSITION. - Google Patents

CONDON WITH A COATING AND COMPOSITION. Download PDF

Info

Publication number
ES2281894T3
ES2281894T3 ES05715894T ES05715894T ES2281894T3 ES 2281894 T3 ES2281894 T3 ES 2281894T3 ES 05715894 T ES05715894 T ES 05715894T ES 05715894 T ES05715894 T ES 05715894T ES 2281894 T3 ES2281894 T3 ES 2281894T3
Authority
ES
Spain
Prior art keywords
condom
coating
composition
penis
erection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05715894T
Other languages
Spanish (es)
Inventor
Achim Brucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2281894T3 publication Critical patent/ES2281894T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
    • A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Nursing (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a condom with a coating for supporting the male erection, said coating being applied to an inner surface of the condom and containing a ginger root extract, a calcium antagonist (calcium channel blocker) and the agent minoxidil or aminexil. The invention further relates to a composition and use of a combination of compounds to give a composition for local application on the penis.

Description

Condón con un revestimiento y composición.Condom with a coating and composition.

La presente invención se refiere a un condón con un revestimiento sobre una superficie interior del condón para mantener la erección en hombres, en especial en caso de trastornos de la erección. La invención se refiere además a una composición así como a la utilización de una combinación de compuestos para la preparación de una composición para utilización local en el pene.The present invention relates to a condom with a coating on an inner surface of the condom for maintain an erection in men, especially in case of disorders of erection The invention further relates to a composition. as well as the use of a combination of compounds for preparation of a composition for local use in the penis.

Los trastornos de la erección son un problema mundialmente conocido, para el cual existen un gran número de posibilidades de tratamiento. El documento WO 03/088880 A2 da a conocer un condón con un revestimiento vasodilatador sobre una superficie interior del condón. El documento US 2003/0130183 A1 y la patente US nº 5.879.682 dan a conocer composiciones para utilización genital las cuales comprenden, como sustancia vasodilatadora, entre otras, Gingerol. Como posibilidad de tratamiento adicional se propone, por ejemplo, la inyección de composiciones vasodilatadoras en el pene inmediatamente antes de la relación sexual. En el documento EP 1 049 461 B1 se describe, por el contrario, una utilización de una composición para la utilización local en el pene, la cual contiene nitrato de glicerina y lanolina. Allí se describe además que esta composición se puede utilizar junto con un condón. Asimismo, la patente US nº 4.829.991 da a conocer ya un condón con revestimientos interiores los cuales contienen la sustancia activa nitrato de glicerina para el estímulo de la circulación sanguínea.Erection disorders are a problem world famous, for which there are a large number of treatment possibilities WO 03/088880 A2 gives a know a condom with a vasodilator coating on a inner surface of the condom. US 2003/0130183 A1 and the US Patent No. 5,879,682 discloses compositions for use genitals which comprise, as vasodilator substance, between others, Gingerol. As a possibility of additional treatment, proposes, for example, the injection of vasodilator compositions in the penis immediately before sexual intercourse. At EP 1 049 461 B1 describes, on the contrary, a use of a composition for local use in the penis, which contains glycerin nitrate and lanolin. There it is described In addition, this composition can be used together with a condom. Also, US Patent No. 4,829,991 already discloses a condom with inner linings which contain the active substance glycerin nitrate for circulation stimulation blood

Mediante la sustancia activa nitrato de glicerina, con su acción estimulante de la circulación sanguínea, debe mantenerse la erección, pudiendo aparecer sin embargo una caída de la presión sanguínea.Through the active substance nitrate of Glycerin, with its blood circulation stimulating action, The erection must be maintained, although a fall may appear of blood pressure.

La presente invención se plantea el problema de preparar un medio el cual presente una acción mejorada durante la utilización para mantener la erección en los hombres.The present invention poses the problem of prepare a medium which exhibits an improved action during the use to maintain erection in men.

El problema se resuelve según la invención mediante un condón con un revestimiento para el apoyo de la erección en los hombres, estando aplicado el revestimiento sobre una superficie interior del condón y conteniendo extracto de jengibre como única sustancia activa.The problem is solved according to the invention. using a condom with a lining for erection support in men, the coating being applied on a inner surface of the condom and containing ginger extract As the only active substance.

El jengibre tiene, como es sabido, una acción que favorece la circulación sanguínea y mantiene por ello, en caso de utilización de un condón con un revestimiento interior con extracto de raíz de jengibre, la erección del pene.Ginger has, as is known, an action which favors blood circulation and maintains it, in case of using a condom with an inner lining with Ginger root extract, penis erection.

Con el fin de provocar la menor cantidad de irritaciones posibles está previsto, preferentemente, que el revestimiento esté previsto en una zona de la superficie interior del condón la cual, durante la utilización del condón, entre en contacto con la zona del cuerpo cavernoso del pene. Las zonas restantes de la superficie interior del condón no están dotadas con el revestimiento.In order to cause the least amount of possible irritations is preferably provided that the coating is provided on an area of the inner surface of the condom which, during the use of the condom, enters contact with the cavernous body area of the penis. The zones remaining of the inner surface of the condom are not endowed with the coating.

El revestimiento puede estar aplicado también sobre la superficie exterior del condón, con el fin de estimular asimismo a la pareja sexual.The coating may also be applied. on the outer surface of the condom, in order to stimulate also to the sexual partner.

El problema se resuelve además mediante una composición en forma de crema o pomada para la utilización local en el pene para mantener la erección, conteniendo la composición extracto de raíz de jengibre como única sustancia activa.The problem is also solved by composition in the form of cream or ointment for local use in the penis to maintain the erection, containing the composition Ginger root extract as the only active substance.

La crema o pomada puede presentar una composición convencional. Por ejemplo, una pomada puede presentar los componentes almidón de trigo, agua, glicerina, alcohol etílico y adraganto.The cream or ointment may present a conventional composition For example, an ointment may present the components wheat starch, water, glycerin, ethyl alcohol and adraganto

El problema se resuelve además mediante la utilización de una combinación de compuestos durante la preparación de una composición para la utilización local en el pene para el apoyo de la erección, conteniendo la composición extracto de raíz de jengibre como única sustancia activa.The problem is also solved by use of a combination of compounds during preparation of a composition for local use in the penis for erection support, containing the root extract composition of Ginger as the only active substance.

Claims (5)

1. Condón con un revestimiento para mantener la erección en hombres, en el que el revestimiento está aplicado sobre la superficie interior del condón, caracterizado porque el revestimiento contiene extracto de raíz de jengibre como única sustancia activa.1. Condom with a coating to maintain the erection in men, in which the coating is applied on the inside surface of the condom, characterized in that the coating contains ginger root extract as the only active substance. 2. Condón según la reivindicación 1, caracterizado porque el revestimiento está previsto en una zona de la superficie interior del condón la cual, durante la utilización del condón, entra en contacto con la zona del cuerpo cavernoso del pene.2. Condom according to claim 1, characterized in that the coating is provided in an area of the inner surface of the condom which, during the use of the condom, comes into contact with the area of the cavernous body of the penis. 3. Condón según una de las reivindicaciones 1 ó 2, caracterizado porque el revestimiento está aplicado también sobre la superficie exterior del condón.3. Condom according to one of claims 1 or 2, characterized in that the coating is also applied on the outer surface of the condom. 4. Composición en forma de crema o pomada para la utilización local en el pene para mantener la erección, conteniendo la fórmula extracto de raíz de jengibre como única sustancia activa.4. Composition in the form of cream or ointment for local use in the penis to maintain an erection, containing the formula ginger root extract as unique active substance. 5. Utilización de una combinación de compuestos durante la preparación de una composición para la utilización local en el pene para mantener la erección, conteniendo la composición extracto de raíz de jengibre como única sustancia activa.5. Use of a combination of compounds during the preparation of a composition for the local use in the penis to maintain an erection, containing The ginger root extract composition as the only substance active
ES05715894T 2004-04-28 2005-03-10 CONDON WITH A COATING AND COMPOSITION. Active ES2281894T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE202004006803U DE202004006803U1 (en) 2004-04-28 2004-04-28 Condom with a coating and composition
DE202004006803~U 2004-04-28

Publications (1)

Publication Number Publication Date
ES2281894T3 true ES2281894T3 (en) 2007-10-01

Family

ID=32695474

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05715894T Active ES2281894T3 (en) 2004-04-28 2005-03-10 CONDON WITH A COATING AND COMPOSITION.

Country Status (5)

Country Link
EP (1) EP1653895B1 (en)
AT (1) ATE353203T1 (en)
DE (2) DE202004006803U1 (en)
ES (1) ES2281894T3 (en)
WO (1) WO2005107660A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2883167B1 (en) * 2005-03-18 2009-07-10 Oreal CAPILLARY CARE COMPOSITION AND / OR CILES CONTAINING AMINEXIL IN COMBINATION WITH A VASODILATOR, FOR STIMULATING THE GROWTH OF HAIR AND / OR CILES AND / OR BRAKING THEIR FALL, ITS USES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
DE3913954A1 (en) * 1989-04-27 1990-10-31 Stief Georg MEDICINES FOR TREATING ERECTILE DYSFUNCTIONS
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
US5879682A (en) * 1995-11-24 1999-03-09 Peya Biotech Inc Aframonum seeds for improving penile activity
US6482857B1 (en) * 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
AU4167200A (en) * 1999-02-24 2000-09-14 Cognis Corporation Reduction of latex associated hypersensitivity
BR0208197B1 (en) * 2001-03-30 2011-09-20 condom with erectogenic composition.
US6809079B2 (en) * 2002-01-08 2004-10-26 Vasogenix Pharmaceuticals, Inc. Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom

Also Published As

Publication number Publication date
EP1653895B1 (en) 2007-02-07
WO2005107660A1 (en) 2005-11-17
EP1653895A1 (en) 2006-05-10
ATE353203T1 (en) 2007-02-15
DE202004006803U1 (en) 2004-07-08
DE502005000368D1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
PT2465493E (en) Topical compositions for the prevention and treatment of irritation of mucous cells
ES2273509T3 (en) COMPOSITIONS FOR THE TREATMENT OF MALE ERECTILE DIFUTION.
GT200000168A (en) PHARMACEUTICALLY ACTIVE COMPOUNDS.
BR0316753A (en) Treatment method for sexual dysfunction
BRPI0412314B8 (en) compound 3-[2(r)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl -pyrimidine-2,4(1h,3h)-dione, pharmaceutical composition comprising said compound and its use for the treatment of a condition related to sex hormone
CO4970819A1 (en) TREATMENT OF FEMALE SEXUAL DYSFUNCTION IN A HUMAN FEMALE
ECSP045069A (en) USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS
EA200601802A1 (en) DERIVATIVES OF MORPHOLINE
SV2002000250A (en) DRUG DOSE FORMULA OPERATED BY HYDROGEL REF. PC10818AJTB / BB
BR0317747A (en) Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer's disease and mild cognitive impairment
WO2006010589A3 (en) Post foaming gel mousse
AR016993A1 (en) INTRANASAL FORMULATIONS TO TREAT SEXUAL DISORDERS
NO2012015I1 (en) Dapoxetine in any form protected by base patent No. 330562
CY1114448T1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THESE IN WOMEN'S SEXUAL INTERFERENCE
CR8473A (en) VINFLUNINA PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION AND THE PREPARATION PROCESS OF SUCH COMPOSITION
BRPI0519355A2 (en) compounds for treatment against flaviviridae
ES2281894T3 (en) CONDON WITH A COATING AND COMPOSITION.
EP2190431B1 (en) Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation
EP2056799A2 (en) Compositions and methods for treating or preventing glaucoma or progression thereof
SI1797876T1 (en) Combinations of vasoactive agents and their use in the treatment of sexual disfunctions
WO2006053014A3 (en) Selective inhibition of rock1 in cardiac therapy
BRPI0513222A (en) agent for promoting recovery from dysfunction after the onset of central neurological disease
HN2001000038A (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE
PE20010568A1 (en) ORAL CONTROLLED RELEASE FORMULATIONS
WO2008037045A3 (en) Composition containing a mixture of antidepressants for treating premature ejaculation.